Annual EPS
-$0.54
+$0.48+47.06%
31 December 2023
Summary:
Adaptimmune Therapeutics annual earnings per share is currently -$0.54, with the most recent change of +$0.48 (+47.06%) on 31 December 2023. During the last 3 years, it has risen by +$0.36 (+40.00%). ADAP annual EPS is now -2613.57% below its all-time high of -$0.02, reached on 30 June 2013.ADAP EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.06
-$0.30-125.00%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly earnings per share is currently -$0.06, with the most recent change of -$0.30 (-125.00%) on 30 September 2024. Over the past year, it has increased by +$0.12 (+66.67%). ADAP quarterly EPS is now -125.00% below its all-time high of $0.24, reached on 30 June 2024.ADAP Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$0.18
+$0.12+40.00%
30 September 2024
Summary:
Adaptimmune Therapeutics TTM earnings per share is currently -$0.18, with the most recent change of +$0.12 (+40.00%) on 30 September 2024. Over the past year, it has increased by +$0.29 (+62.01%). ADAP TTM EPS is now -2237.66% below its all-time high of -$0.01, reached on 30 September 2014.ADAP TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.1% | +66.7% | +62.0% |
| 3 y3 years | +40.0% | +80.0% | +82.3% |
| 5 y5 years | +43.8% | +83.3% | +87.0% |
ADAP EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.1% | -125.0% | +80.0% | at high | +84.2% |
| 5 y | 5 years | at high | +59.1% | -125.0% | +83.3% | at high | +87.0% |
| alltime | all time | -2613.6% | +59.1% | -125.0% | +87.5% | -2237.7% | +87.0% |
Adaptimmune Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$0.06(-125.0%) | -$0.18(-40.0%) |
| June 2024 | - | $0.24(-233.3%) | -$0.30(-54.5%) |
| Mar 2024 | - | -$0.18(0.0%) | -$0.66(+39.3%) |
| Dec 2023 | -$0.54(-47.1%) | -$0.18(0.0%) | -$0.47(0.0%) |
| Sept 2023 | - | -$0.18(+50.0%) | -$0.47(-11.2%) |
| June 2023 | - | -$0.12(-2035.5%) | -$0.53(-25.2%) |
| Mar 2023 | - | $0.01(-103.4%) | -$0.71(-30.0%) |
| Dec 2022 | -$1.02(0.0%) | -$0.18(-25.0%) | -$1.02(-5.6%) |
| Sept 2022 | - | -$0.24(-20.0%) | -$1.08(-5.3%) |
| June 2022 | - | -$0.30(0.0%) | -$1.14(+5.6%) |
| Mar 2022 | - | -$0.30(+25.0%) | -$1.08(+5.9%) |
| Dec 2021 | -$1.02(+13.3%) | -$0.24(-20.0%) | -$1.02(0.0%) |
| Sept 2021 | - | -$0.30(+25.0%) | -$1.02(+6.3%) |
| June 2021 | - | -$0.24(0.0%) | -$0.96(0.0%) |
| Mar 2021 | - | -$0.24(0.0%) | -$0.96(0.0%) |
| Dec 2020 | -$0.90(-31.8%) | -$0.24(0.0%) | -$0.96(-5.9%) |
| Sept 2020 | - | -$0.24(0.0%) | -$1.02(-10.5%) |
| June 2020 | - | -$0.24(0.0%) | -$1.14(-13.6%) |
| Mar 2020 | - | -$0.24(-20.0%) | -$1.32(0.0%) |
| Dec 2019 | -$1.32 | -$0.30(-16.7%) | -$1.32(-4.3%) |
| Sept 2019 | - | -$0.36(-14.3%) | -$1.38(+43.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$0.42(+75.0%) | -$0.96(-5.9%) |
| Mar 2019 | - | -$0.24(-33.3%) | -$1.02(0.0%) |
| Dec 2018 | -$0.96(+23.1%) | -$0.36(-700.0%) | -$1.02(+6.3%) |
| Sept 2018 | - | $0.06(-112.5%) | -$0.96(-6.7%) |
| June 2018 | - | -$0.48(+100.0%) | -$1.03(+30.4%) |
| Mar 2018 | - | -$0.24(-20.0%) | -$0.79(-7.1%) |
| Dec 2017 | -$0.78(-23.5%) | -$0.30(+3091.5%) | -$0.85(+7.6%) |
| Sept 2017 | - | -$0.01(-96.1%) | -$0.79(-22.6%) |
| June 2017 | - | -$0.24(-20.0%) | -$1.02(-5.6%) |
| Mar 2017 | - | -$0.30(+25.0%) | -$1.08(+5.9%) |
| Dec 2016 | -$1.02(+240.0%) | -$0.24(0.0%) | -$1.02(+30.8%) |
| Sept 2016 | - | -$0.24(-20.0%) | -$0.78(+39.7%) |
| June 2016 | - | -$0.30(+25.0%) | -$0.56(+116.2%) |
| Mar 2016 | - | -$0.24(+1218.7%) | -$0.26(+1079.0%) |
| Dec 2015 | -$0.30(-70.6%) | - | - |
| Sept 2015 | - | -$0.02(+391.9%) | -$0.02(+92.1%) |
| June 2015 | -$1.02(+3636.3%) | - | - |
| Dec 2014 | - | -$0.00(-51.9%) | -$0.01(+48.1%) |
| Sept 2014 | - | -$0.01 | -$0.01 |
| June 2014 | -$0.03(+37.2%) | - | - |
| June 2013 | -$0.02 | - | - |
FAQ
- What is Adaptimmune Therapeutics annual earnings per share?
- What is the all time high annual EPS for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual EPS year-on-year change?
- What is Adaptimmune Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly EPS year-on-year change?
- What is Adaptimmune Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics TTM EPS year-on-year change?
What is Adaptimmune Therapeutics annual earnings per share?
The current annual EPS of ADAP is -$0.54
What is the all time high annual EPS for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual earnings per share is -$0.02
What is Adaptimmune Therapeutics annual EPS year-on-year change?
Over the past year, ADAP annual earnings per share has changed by +$0.48 (+47.06%)
What is Adaptimmune Therapeutics quarterly earnings per share?
The current quarterly EPS of ADAP is -$0.06
What is the all time high quarterly EPS for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly earnings per share is $0.24
What is Adaptimmune Therapeutics quarterly EPS year-on-year change?
Over the past year, ADAP quarterly earnings per share has changed by +$0.12 (+66.67%)
What is Adaptimmune Therapeutics TTM earnings per share?
The current TTM EPS of ADAP is -$0.18
What is the all time high TTM EPS for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high TTM earnings per share is -$0.01
What is Adaptimmune Therapeutics TTM EPS year-on-year change?
Over the past year, ADAP TTM earnings per share has changed by +$0.29 (+62.01%)